Literature DB >> 24698767

α-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy.

Verena E L May1, Benjamin Ettle1, Anne-Maria Poehler1, Silke Nuber2, Kiren Ubhi2, Edward Rockenstein2, Beate Winner3, Michael Wegner4, Eliezer Masliah2, Jürgen Winkler5.   

Abstract

Multiple system atrophy (MSA), an atypical parkinsonian disorder, is characterized by α-synuclein (α-syn(+)) cytoplasmatic inclusions in mature oligodendrocytes. Oligodendrocyte progenitor cells (OPCs) represent a distinct cell population with the potential to replace dysfunctional oligodendrocytes. However, the role of OPCs in MSA and their potential to replace mature oligodendrocytes is still unclear. A postmortem analysis in MSA patients revealed α-syn within OPCs and an increased number of striatal OPCs. In an MSA mouse model, an age-dependent increase of dividing OPCs within the striatum and the cortex was detected. Despite of myelin loss, there was no reduction of mature oligodendrocytes in the corpus callosum or the striatum. Dissecting the underlying molecular mechanisms an oligodendroglial cell line expressing human α-syn revealed that α-syn delays OPC maturation by severely downregulating myelin-gene regulatory factor and myelin basic protein. Brain-derived neurotrophic factor was reduced in MSA models and its in vitro supplementation partially restored the phenotype. Taken together, efficacious induction of OPC maturation may open the window to restore glial and neuronal function in MSA.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alpha-synuclein; CG4; Differentiation; Multiple system atrophy; Myelin basic protein; Oligodendrocyte precursors; Oligodendrogenesis; Platelet derived growth factor receptor alpha; Transgenic; maturation

Mesh:

Substances:

Year:  2014        PMID: 24698767      PMCID: PMC4087058          DOI: 10.1016/j.neurobiolaging.2014.02.028

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  57 in total

Review 1.  Regulation of oligodendrocyte differentiation and myelination.

Authors:  Ben Emery
Journal:  Science       Date:  2010-11-05       Impact factor: 47.728

2.  Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway.

Authors:  Jochen Klucken; Anne-Maria Poehler; Darius Ebrahimi-Fakhari; Jacqueline Schneider; Silke Nuber; Edward Rockenstein; Ursula Schlötzer-Schrehardt; Bradley T Hyman; Pamela J McLean; Eliezer Masliah; Juergen Winkler
Journal:  Autophagy       Date:  2012-05-01       Impact factor: 16.016

3.  Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes.

Authors:  Philipp J Kahle; Manuela Neumann; Laurence Ozmen; Veronika Muller; Helmut Jacobsen; Will Spooren; Babette Fuss; Barbara Mallon; Wendy B Macklin; Hideo Fujiwara; Masato Hasegawa; Takeshi Iwatsubo; Hans A Kretzschmar; Christian Haass
Journal:  EMBO Rep       Date:  2002-05-24       Impact factor: 8.807

4.  Brain-derived neurotrophic factor promotes central nervous system myelination via a direct effect upon oligodendrocytes.

Authors:  Junhua Xiao; Agnes W Wong; Melanie M Willingham; Maarten van den Buuse; Trevor J Kilpatrick; Simon S Murray
Journal:  Neurosignals       Date:  2011-01-18

5.  Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination.

Authors:  Ben Emery; Dritan Agalliu; John D Cahoy; Trent A Watkins; Jason C Dugas; Sara B Mulinyawe; Adilijan Ibrahim; Keith L Ligon; David H Rowitch; Ben A Barres
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

6.  Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

Authors:  M I Papp; J E Kahn; P L Lantos
Journal:  J Neurol Sci       Date:  1989-12       Impact factor: 3.181

7.  Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy.

Authors:  Nadia Stefanova; Markus Reindl; Manuela Neumann; Christian Haass; Werner Poewe; Philipp J Kahle; Gregor K Wenning
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

8.  Notch receptor activation inhibits oligodendrocyte differentiation.

Authors:  S Wang; A D Sdrulla; G diSibio; G Bush; D Nofziger; C Hicks; G Weinmaster; B A Barres
Journal:  Neuron       Date:  1998-07       Impact factor: 17.173

9.  Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation.

Authors:  Gareth R John; Sai Latha Shankar; Bridget Shafit-Zagardo; Aldo Massimi; Sunhee C Lee; Cedric S Raine; Celia F Brosnan
Journal:  Nat Med       Date:  2002-09-23       Impact factor: 53.440

Review 10.  The neuropathology, pathophysiology and genetics of multiple system atrophy.

Authors:  Z Ahmed; Y T Asi; A Sailer; A J Lees; H Houlden; T Revesz; J L Holton
Journal:  Neuropathol Appl Neurobiol       Date:  2012-02       Impact factor: 8.090

View more
  35 in total

1.  Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines.

Authors:  Amanda L Woerman; Abby Oehler; Sabeen A Kazmi; Jisoo Lee; Glenda M Halliday; Lefkos T Middleton; Steve M Gentleman; Daniel A Mordes; Salvatore Spina; Lea T Grinberg; Steven H Olson; Stanley B Prusiner
Journal:  Acta Neuropathol       Date:  2019-01-28       Impact factor: 17.088

2.  FTY720-Mitoxy reduces toxicity associated with MSA-like α-synuclein and oxidative stress by increasing trophic factor expression and myelin protein in OLN-93 oligodendroglia cell cultures.

Authors:  Javier Vargas-Medrano; Ismael Segura-Ulate; Barbara Yang; Ramesh Chinnasamy; Jeffrey B Arterburn; Ruth G Perez
Journal:  Neuropharmacology       Date:  2019-07-07       Impact factor: 5.250

3.  α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.

Authors:  Benjamin Ettle; Bilal E Kerman; Elvira Valera; Clarissa Gillmann; Johannes C M Schlachetzki; Simone Reiprich; Christian Büttner; Arif B Ekici; André Reis; Michael Wegner; Tobias Bäuerle; Markus J Riemenschneider; Eliezer Masliah; Fred H Gage; Jürgen Winkler
Journal:  Acta Neuropathol       Date:  2016-04-08       Impact factor: 17.088

Review 4.  Multiple System Atrophy - State of the Art.

Authors:  Brice Laurens; Sylvain Vergnet; Miguel Cuina Lopez; Alexandra Foubert-Samier; François Tison; Pierre-Olivier Fernagut; Wassilios G Meissner
Journal:  Curr Neurol Neurosci Rep       Date:  2017-05       Impact factor: 5.081

Review 5.  Multiple system atrophy.

Authors:  Werner Poewe; Iva Stankovic; Glenda Halliday; Wassilios G Meissner; Gregor K Wenning; Maria Teresa Pellecchia; Klaus Seppi; Jose-Alberto Palma; Horacio Kaufmann
Journal:  Nat Rev Dis Primers       Date:  2022-08-25       Impact factor: 65.038

Review 6.  Multiple system atrophy: pathogenic mechanisms and biomarkers.

Authors:  Kurt A Jellinger; Gregor K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2016-04-20       Impact factor: 3.575

7.  Intracellular alpha-synuclein affects early maturation of primary oligodendrocyte progenitor cells.

Authors:  Benjamin Ettle; Simone Reiprich; Janina Deusser; Johannes C M Schlachetzki; Wei Xiang; Iryna Prots; Eliezer Masliah; Beate Winner; Michael Wegner; Jürgen Winkler
Journal:  Mol Cell Neurosci       Date:  2014-07-11       Impact factor: 4.314

Review 8.  Up-regulation of SNCA gene expression: implications to synucleinopathies.

Authors:  L Tagliafierro; O Chiba-Falek
Journal:  Neurogenetics       Date:  2016-03-07       Impact factor: 2.660

Review 9.  Multiple system atrophy: experimental models and reality.

Authors:  Cassia Overk; Edward Rockenstein; Elvira Valera; Nadia Stefanova; Gregor Wenning; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2017-10-20       Impact factor: 17.088

10.  FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models.

Authors:  Guadalupe Vidal-Martinez; Ismael Segura-Ulate; Barbara Yang; Valeria Diaz-Pacheco; Jose A Barragan; Jocelyn De-Leon Esquivel; Stephanie A Chaparro; Javier Vargas-Medrano; Ruth G Perez
Journal:  Exp Neurol       Date:  2019-11-18       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.